Paige E Lysne, MPH, CCRC, ACRP-CP
Study Coordinator III
On This Page
Publications
Academic Articles
-
Effects of Prefrontal Transcranial Direct Current Stimulation on Retention of Performance Gains on an Obstacle Negotiation Task in Older Adults.
- Journal
- Neuromodulation : journal of the International Neuromodulation Society.
- Volume/Issue
- 26(4):829-839
- [DOI]
- 10.1016/j.neurom.2022.02.231.
- [PMID]
- 35410769.
-
Somatosensory impairment of the feet is associated with higher activation of prefrontal cortex during walking in older adults.
- Journal
- Experimental gerontology.
- Volume/Issue
- 165
- [DOI]
- 10.1016/j.exger.2022.111845.
- [PMID]
- 35644417.
-
Adaptability and Resilience in Aging Adults (ARIAA): protocol for a pilot and feasibility study in chronic low back pain.
- Journal
- Pilot and feasibility studies.
- Volume/Issue
- 7(1)
- [DOI]
- 10.1186/s40814-021-00923-y.
- [PMID]
- 34666839.
-
Pain and the Montreal Cognitive Assessment (MoCA) in Aging.
- Journal
- Pain medicine (Malden, Mass.).
- Volume/Issue
- 22(8):1776-1783
- [DOI]
- 10.1093/pm/pnab003.
- [PMID]
- 33718961.
-
Combining Frontal Transcranial Direct Current Stimulation With Walking Rehabilitation to Enhance Mobility and Executive Function: A Pilot Clinical Trial.
- Journal
- Neuromodulation : journal of the International Neuromodulation Society.
- Volume/Issue
- 24(5):950-959
- [DOI]
- 10.1111/ner.13250.
- [PMID]
- 32808403.
-
Obstacle Negotiation in Older Adults: Prefrontal Activation Interpreted Through Conceptual Models of Brain Aging.
- Journal
- Innovation in aging.
- Volume/Issue
- 4(4)
- [DOI]
- 10.1093/geroni/igaa034.
- [PMID]
- 32995566.
-
Age and pain differences in non-verbal fluency performance: Associations with cortical thickness and subcortical volumes.
- Journal
- Experimental gerontology.
- Volume/Issue
- 126
- [DOI]
- 10.1016/j.exger.2019.110708.
- [PMID]
- 31445107.
Grants
-
A randomized phase 3 trial of fludarabine/cytarabine/gemtuzumab ozogamicin with or without venetoclax in children with relapsed AML
Active
- Role:
- Other
- Funding:
- BLOOD CANCER UNITED
-
A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (IND#:133494, NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
Active
- Role:
- Other
- Funding:
- PUBLIC HLTH INST via SERVIER PHARMACEUTICALS
-
A Phase 3 Randomized Trial of Inotuzumab Ozogamicin (IND#:133494, NSC#: 772518) for Newly Diagnosed High-Risk B-ALL; Risk-Adapted Post-Induction Therapy for High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and Disseminated B-LLy
Active
- Role:
- Other
- Funding:
- PUBLIC HLTH INST via JAZZ PHARMACEUTICALS
-
A PHASE II, RANDOMIZED, OPEN-LABEL STUDY TO ASSESS THE EFFICACY, SAFETY, AND PHARMACOKINETICS (PK) OF MAINTENANCE CABOZANTINIB (XL184) PLUS BEST SUPPORTIVE CARE (BSC) VERSUS BSC IN CHILDREN, ADOLESCENTS AND YOUNG ADULTS (AYA) WITH UNRESECTABLE RESIDUAL OSTEOSARCOMA EITHER AT DIAGNOSIS OR AT FIRST RELAPSE AFTER STANDARD TREATMENT
Active
- Role:
- Other
- Funding:
- PAREXEL INTERNATIONAL PTY via IPSEN BIOPHARMACEUTICALS
Contact Details
- Business:
- (352) 294-8743
- Business:
- plysne@ufl.edu
- Business Mailing:
-
1600 SW ARCHER RD # M354
GAINESVILLE FL 32610 - Business Street:
-
1600 SW ARCHER RD
GAINESVILLE FL 32610